Home › Calculator › SPRB Dividend Calculator 2026
SPRB Dividend DRIP Calculator 2026
4.13% YieldHealthcareSpruce Biosciences, Inc. · NASDAQ
Price: $48.38 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When SPRB pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your SPRB snowball 📈
$10,000 in SPRB → $15.0K in 10 years · $49.60/month
About Spruce Biosciences, Inc. (SPRB) — Dividend Analysis 2026
Spruce Biosciences, Inc., founded in 2014 and situated in Daly City, California, operates as a biopharmaceutical enterprise. Its primary objective is to advance and bring to market innovative treatments, particularly for uncommon endocrine conditions. A central component of its therapeutic pipeline is tildacerfont, a non-steroidal drug candidate. This compound is currently undergoing Phase 2b clinical assessments in adult patients with congenital adrenal hyperplasia (CAH), with the aim of optimizing disease management and lessening dependence on steroid medications by examining reductions in glucocorticoid levels and their clinical consequences. Tildacerfont is also progressing through Phase 2 trials for pediatric classic CAH, as well as investigating its efficacy in women suffering from polycystic ovary syndrome (PCOS). Additionally, Spruce Biosciences maintains a collaborative licensing agreement with Eli Lilly and Company to jointly explore, formulate, and commercialize various pharmaceutical substances.
Compare SPRB with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full SPRB DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open SPRB position with:
🌍 SPRB Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold SPRB.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 4.13% | 1.33% | $413 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 3.51% | 0.71% | $351 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 3.30% | 0.50% | $330 / yr |
| 🇬🇧 UK ISA | 0% | 4.13% | 1.33% | $413 / yr |
| 🇬🇧 UK Taxable | 8.75% | 3.77% | 0.97% | $377 / yr |
| 🇨🇦 TFSA | 0% | 4.13% | 1.33% | $413 / yr |
| 🇨🇦 CA Taxable | 25% | 3.10% | 0.30% | $310 / yr |
| 🇦🇺 Super (pension) | 15% | 3.51% | 0.71% | $351 / yr |
| 🇦🇺 AU Taxable | 30% | 2.89% | 0.09% | $289 / yr |
| 🇩🇪 DE Taxable | 26.375% | 3.04% | 0.24% | $304 / yr |
| 🇫🇷 FR Taxable | 30% | 2.89% | 0.09% | $289 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 SPRB Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 SPRB Dividend Payment Schedule
SPRB pays quarterly — 4 times per year. Next ex-div: TBD.
📊 SPRB vs Healthcare Benchmarks
How SPRB compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for SPRB sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ SPRB Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2026-06-30 | 266 | $4.53 | $1.2K | ||
| A-Award | 2026-05-21 | 1,700 | $52.70 | $89.6K | ||
| A-Award | 2026-05-21 | 1,700 | $52.70 | $89.6K | ||
| A-Award | 2026-05-21 | 1,700 | $52.70 | $89.6K | ||
| A-Award | 2026-05-21 | 1,700 | $52.70 | $89.6K | ||
| A-Award | 2026-05-21 | 1,700 | $52.70 | $89.6K | ||
| A-Award | 2026-03-09 | 11,000 | — | — | ||
| A-Award | 2025-12-11 | 5,000 | — | — | ||
| M-Exempt | 2025-12-11 | 1,250 | — | — | ||
| M-Exempt | 2025-12-11 | 1,250 | — | — |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the SPRB dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Spruce Biosciences, Inc. (SPRB) is currently trading at $48.38, 97% below its 52-week high. The current dividend yield is 4.13% based on an annual payout of $2.00 per share.
SPRB (Spruce Biosciences, Inc.) — 4.13% Dividend Yield Analysis
Spruce Biosciences, Inc. (SPRB) is a healthcare stock currently trading at $48.38 with a dividend yield of 4.13%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Dividend payments are not guaranteed and can be reduced or suspended at any time.
Auto-generated from live market data. For educational purposes only — not financial advice.